Rationale: Platelets may interact with the immune system in tuberculosis (TB) to regulate human inflammatory responses that lead to morbidity and spread of infection.
Approximately 2 billion people are infected with Mycobacterium tuberculosis (M.tb), which killed approximately 1.8 million people in 2015 alone (1) . In pulmonary tuberculosis (TB), inflammatory tissue damage leads to cavity formation and, ultimately, morbidity, mortality, and onward transmission (2) . This journal has recognized the importance of the host response to M.tb throughout its 100-year history (3) , and, with drug resistance increasing worldwide and limited new therapies, there is an increasing interest in host-directed therapy for TB. Further understanding of TB immunopathology is needed to support progress in this area.
In addition to their classic role in hemostasis, platelets modulate innate and adaptive immune responses (4) . Platelet interaction with monocytes regulates cell recruitment, maturation, and secretion of cytokines and MMPs (matrix metalloproteinases) (5) (6) (7) . High platelet numbers are found in pulmonary vessels, and the lung (the main target organ for M.tb) is a major site of platelet production (8) . Both platelet count and activity are increased in TB (9, 10) . Platelets express surface markers, such as CD41 (cluster of differentiation 41) (11) , and on activation secrete mediators from their granules. These include PF4 (platelet factor-4), which is primarily platelet secreted, and PDGF-BB (platelet-derived growth factor-BB), RANTES (regulated upon activation, normal T cell expressed and secreted), P-selectin, and MMP-9, which are also secreted by other cell types (12) (13) (14) . PTX3 (pentraxin-3) interacts with platelet-derived P-selectin to regulate platelet activity (15) .
Central to TB pathology is development of a tissue-degrading phenotype due to innate immune cell activation (2, 16) . M.tb infection upregulates intercellular networks and secretion of cytokines such as IL-1b, IL-10, and IL-12, which influence replication, spread, and persistence of M.tb (17) . Innate immune responses also drive secretion of MMPs, such as the collagenase MMP-1, and these degrade the pulmonary extracellular matrix to cause tissue destruction (18) . As well as transcriptional regulation, MMP activity is regulated post-translationally by TIMPs (tissue inhibitors of metalloproteinases) and other MMPs, such as MMP-10, which regulates MMP-1 (19, 20) .
Monocytes migrate early from the circulation into M.tb-infected tissue, where they differentiate to specialized cell types that control bacterial replication, granuloma formation, and inflammatory tissue destruction (21) (22) (23) . Platelets may influence monocyte maturation and cytokine responses to M.tb antigens and bacillus Calmette-Guérin stimulation, and they drive development of multinucleated giant cells (24) . However, platelet regulation of monocyte functions is not understood in the context of TB immunopathology.
In this study, we investigate the hypothesis that platelets have a key role in inflammatory tissue destruction in pulmonary TB. We demonstrate platelet activation in the circulation of patients with pulmonary TB. We establish platelets to be key regulators of M.tb-driven monocyte collagen degradation and demonstrate a role of platelets in the control of intracellular monocytic bacterial replication. Finally, we show platelets at the site of infection in pulmonary TB.
Methods
Further information on methodology is in the online supplement.
Clinical Studies
Plasma samples were collected in prospective studies from 50 adult patients with TB in Lima, Peru with a new diagnosis of culturepositive, drug-sensitive pulmonary TB (25) . Fifty age-and sex-matched healthy control subjects were asymptomatic and PPD negative. All patients provided written informed consent, and the study had ethical approval from Universidad Peruana Cayetano Heredia, the Asociación Benéfica PRISMA, and each participating center's ethics committee. Appetite was assessed using the Short Nutritional Assessment Questionnaire (SNAQ). Plasma and sputum samples were obtained at Day 0, and plasma samples were collected from 25 patients longitudinally at Days 14, 28, and 60 of treatment.
BAL fluid (BALF) was collected from patients in a previously described study (26) .
Cell Isolation and Culture
Human platelets were isolated and activated with 0.1 U/ml thrombin (27) . Monocytes were isolated using either adhesion purification or, for confocal microscopy, the Pan Monocyte Isolation (Human) Kit (Miltenyi Biotec). M. tuberculosis H37Rv Pasteur (M.tb) was cultured in Middlebrook 7H9 medium (28) .
Autologous freshly isolated platelets and monocytes from healthy volunteers were cocultured at a ratio of 100:1 unless otherwise stated and infected with M.tb at a multiplicity of infection of 1.
Secreted Cytokine and MMP Analysis
Clinical samples were analyzed by Luminex magnetic bead array (R&D Systems). ELISA or Luminex array were used to measure cell culture concentrations of MMPs, TIMPs (both R&D Systems), and cytokines (Millipore).
Cytokine and MMP Gene Analysis
RNA was extracted and qRT-PCR performed using b-actin as a reference gene (One-Step RT-PCR master mix; Qiagen). PCR plasmid standards were used to calculate copy number of MMP-1 and b-actin mRNA and fold change compared with controls.
Colony-Forming Unit Analysis
Lysed adherent cells or culture supernatants were plated onto Middlebrook 7H11 agar and incubated at 37 8 C for 2 to 4 weeks before colony-forming unit counting.
Functional Assay of Tissue Destruction by Confocal Microscopy
Cells were cultured on slides coated with DQ collagen type 1 (ThermoFisher Scientific) and imaged with a Leica confocal microscope. Images were processed using Leica LAS AF Lite 2.6.0 and Image J 1.43 U software (NIH). 
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Results
Active Platelet-associated Mediators Circulating in Patients with TB Clinical characteristics of the 50 patients with newly diagnosed TB and 50 healthy control subjects matched for age and sex are presented in Table 1 . Patients with TB weighed less and had a significantly lower body mass index (BMI) than control subjects at recruitment (BMI, 20.4 vs. 27.2, respectively; P , 0.0001), and appetite measured by SNAQ was poor compared with control subjects (P , 0.001).
PDGF-BB, RANTES, and PF4 concentrations were significantly upregulated in patients compared with control subjects (all P , 0.0001; Figures 1A-1C) . MMP-9 concentrations were higher in untreated patients with TB versus healthy control subjects (89,124 pg/ml and 68,057 pg/ml, respectively) (P , 0.05; Figure 1D ), as were PTX3 concentrations (433 pg/ml and 94.0 pg/ml, respectively) (P , 0.001; Figure 1E ). There was no difference in P-selectin concentration (P , 0.05; Figure 1F ).
In patients with TB, there was strong correlation between concentrations of PDGF-BB and PF4 (R = 0.89), PDGF-BB and RANTES (R = 0.65), and PF4 and RANTES (R = 0.70). There was a moderate correlation between PF4 and MMP-9 concentrations (R = 0.54) and a weaker correlation between concentrations of MMP-9 and PTX3 (R = 0.47), MMP-9 and PDGF-BB (R = 0.45), PTX3 and PDGF-BB (R = 0.48), PDGF-BB and P-selectin (R = 0.45), and PF4 and PTX3 (R = 0.44). Among control subjects, there was strong correlation between levels of RANTES and PDGF-BB (R = 0.93), RANTES and PF4 (R = 0.87), and PDGF-BB and PF4 (R = 0.88). There was moderate correlation between concentrations of PTX3 and PDGF-BB (R = 0.56) and between PTX3 and PF4 (R = 0.50) and weaker correlation between PTX3 and RANTES (R = 0.49; all P , 0.05).
Longitudinal Changes in Plateletderived Mediators during Treatment of Patients with TB
Next, we performed a longitudinal assessment of platelet activity over the first 60 days of TB treatment in 25 patients. Biometric and microbiological data are shown in Table E1 in the online supplement. A total of 31 of 50 patients (62%) remained sputum culture positive at Day 14, 20 patients (40%) at Day 28, and 5 patients (10%) at Day 60. Mean BMI of patients with TB steadily increased from 20.4 at baseline to 22.0 by Day 60, and mean SNAQ score increased from 13.3 to 15.9. There was no difference in age, sex, mean BMI, or mean SNAQ score between patients with TB who were followed up and those who were not (data not shown).
Over 60 days of treatment, plasma concentrations of PF4 and PDGF-BB changed significantly in patients with TB (P , 0.05; Figures 2A and 2B ). There was a trend toward an increase at Day 14, but concentrations subsequently decreased to near control values by Day 60 (Figures 2A  and 2B ). P-selectin concentrations, which were not upregulated at presentation with TB, did not alter during treatment ( Figure 2C ).
Platelet-Monocyte Interactions Drive MMP-1 and -10 Gene Expression and Secretion in TB
Because there was good evidence of platelet activation in patients with TB, we developed a coculture model to investigate the functional role of platelets in regulating the human inflammatory immune response. A major outcome of this response is MMPdriven extracellular matrix destruction, in which the collagenase MMP-1 is key (16) . Monocytes costimulated with platelets and M.tb had a 4.3-fold increase in Mmp-1 expression compared with M.tb-stimulated monocytes alone (P , 0.0001; Figure 3A ). Platelets did not significantly upregulate Mmp-1 expression in uninfected monocytes. MMP-1 secretion was increased 6.6-fold from M.tb-stimulated monocytes cocultured with platelets compared with M.tb-infected monocytes alone (P , 0.0001; Figure 3B ), Figure 3C ), increasing up to 100:1. The MMP-1 activator MMP-10 was similarly upregulated by platelets. MMP-10 concentrations increased from 318 6 106.9 pg/ml to 1,972 6 405.4 pg/ml on exposure to M.tb. This increased further to 3,423 6 363.2 pg/ml with exposure to M.tb in the presence of platelets (both P , 0.001; Figure 3D ). Significant MMP-10 upregulation was seen, with P:M ratios of 50:1 (P , 0.01), and this increased further at a ratio of 100:1 ( Figure 3E ). However, MMP-10 secretion decreased with P:M ratio of 500:1 to below that seen with monocytes stimulated by M.tb alone (P , 0.0001; Figure 3E ). In addition, platelet coculture increased monocyte secretion of MMP-3, -7 and -9, whereas MMP-8 was not changed. Similar to MMP-1 and -10, platelet upregulation of MMP-3 and -7 required M.tb exposure ( Figure E1 ). TIMP-1 and -2 secretion from monocytes in the presence or absence of M.tb was not altered by platelet coculture (Figures 3F and 3G ).
Platelets Regulate MonocyteDependent Collagen Destruction in TB
To investigate the impact of platelets on monocytes' functional MMP-1 activity, monocytes were cultured on type I collagen that fluoresces on degradation. Confocal (matrix metalloproteinase-9), and (E) PTX-3 (pentraxin-3) were higher in patients with pulmonary TB before treatment (gray boxes) than age-and sex-matched healthy control subjects (white boxes). (F) Plasma concentrations of P-selectin were unchanged in patients with TB compared with control subjects. Data are presented as median and interquartile range. Whiskers represent 10th and 90th percentiles, and outlier values are shown. P values calculated using the Wilcoxon matched-pairs signed rank test. n = 50 for both groups. *P , 0.05, ***P , 0.001, ****P , 0.0001. Data are mean 6 SD and are representative of at least three independent experiments. *P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001. microscopy revealed monocytes alone had minimal collagenase activity when uninfected, regardless of platelet coculture. M.tb stimulation of monocytes induced some functional collagenase response, but this was significantly increased in monocytes stimulated by M.tb in the presence of platelets ( Figure 4A ). Quantitative analysis revealed a 2.5-fold increase in collagenase activity of M.tb-exposed cocultured cells compared with M.tb-exposed monocytes in the absence of platelets (P , 0.01; Figure 4B ). Platelet-only controls produced no measurable collagen degradation (not shown).
Controls
Platelet Regulation of Monocyte Inflammatory Responses
Next, we investigated the effect of platelet-monocyte interactions on the secretion of inflammatory cytokines. There was a marked increase in IL-1b secretion from M.tb-stimulated monocytes in the presence of platelets compared with M.tb-stimulated monocytes alone (P , 0.0001; Figure 5A ). This trend was not seen in the inflammatory cytokines IFN-g ( Figure 5B ) or tumor necrosis factor (TNF)-a ( Figure 5C ). IL-10 was upregulated 7.5-fold in M.tb-infected platelet coculture compared with single-culture monocytes (P , 0.0001; Figure 5D ). In contrast, M.tb-infected monocytes in platelet coculture secreted 6.4-fold less IL-12 and 6.1-fold less monocyte-derived chemokine (MDC) (both P , 0.001; Figures 5E and 5F ). There was no platelet regulation of the immunomodulatory cytokine IL-6 or the chemokine IL-8 ( Figure E2 ).
Platelet Coculture Increases Monocyte Intracellular M.tb Replication
In addition to regulation of monocytederived inflammatory mediators, monocyte coculture with platelets altered the intracellular killing of M.tb. Although extracellular M.tb did not change in platelet coculture, 2.5-fold more viable intracellular M.tb was detected in cocultured cell lysates (P , 0.001; Figure 6 ).
Active Platelets Are Present at the Site of Infection in Pulmonary TB
Next, we investigated whether platelets were present at the site of TB infection itself. Like most murine TB models, Balb/C mice do not form organized granulomas with central necrosis, but M.tb infection and dissemination through tissue does result in large areas of highly inflamed pulmonary tissue. Therefore, we stained lung tissue from a murine model of infection for the platelet marker CD41 (Figures 7A and 7B) . Platelets are anucleate cells, and this is predominately reflected by the staining. Interestingly, there were large numbers of platelets detected in the alveoli. Limited CD41 association with nucleated cells can be seen, which is largely restricted to areas of granuloma-like structure and giant multinucleate cell formation. In peripheral lung areas with limited inflammation, there was minimal detection of platelets ( Figure 7C ).
To confirm that platelets were active at the site of infection, human BALF samples obtained during a previous clinical study (26) were analyzed for platelet-derived mediators and compared with respiratory symptomatic control patients. There was a significant upregulation of PDGF-BB concentration in BALF from patients with TB compared with control subjects (P , 0.01; Figure 7D ). Both P-selectin and RANTES concentrations were also increased in patients with TB (P , 0.01; Figures 7E and 7F), but PF4 concentrations were not ( Figure 7G ). In human BALF, P-selectin concentrations correlated significantly with increasing concentrations of IL-1b and MMP-1 (both P , 0.001), and MMP-7, -8, and -9 (all P , 0.01) (R = 0.5; Figures  8A-8E ). P-selectin correlation with MMP-3 was also statistically significant (R = 0.4; P , 0.05; Figure 8F ). In addition, BALF PDGF-BB concentrations correlated with MMP-1, -3, -8, and -9 ( Figure E3 ). BALF RANTES concentrations correlated with MMP-1, -8, and -9 as well as IL-1b ( Figure E4 ).
Discussion
This study used a longitudinal patient study, a human cellular model, a murine model, and a more invasive bronchoscopy-based clinical study to investigate the activation and function of platelets in the innate inflammatory response to TB. Plasma concentrations of platelet-associated factors were significantly upregulated in a cohort of patients with pulmonary TB. This is consistent with reports that concentrations of PTX3 (30) and PF4 (10, 31, 32) increase in pulmonary TB along with various platelet indices, such as platelet count and mean platelet volume (9, 33) . In our study, there was a transient increase in plateletassociated mediators when patients received anti-TB treatment followed by a decrease toward plasma concentrations of healthy control subjects. These mediators are not necessarily exclusively produced by platelets. 
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Fox, Kirwan, Whittington, et al.: Platelets Regulate Inflammation in TuberculosisHowever, the concentrations of different platelet-derived mediators were significantly correlated, and this is consistent with costorage and cosecretion. Interestingly, plasma PF4 levels have been previously correlated with TB disease activity (31) . As the secretion of the collagenase MMP-1 is a key driver of tissue destruction of the lung observed in TB (18), we investigated the role of platelets on monocyte MMP-1 secretion in detail using platelet monocyte ratios similar to those observed in humans. Platelets were added to monocytes in a thrombin-activated form, reflecting the activated state we observed in our clinical studies and in keeping with techniques standard across the literature (34) (35) (36) . In macrophages produced in vitro from platelet-matured monocytes, Mmp-1 is among the top five upregulated genes (24) . Platelets alone do not regulate monocyte MMP-1 gene expression or secretion, which may reflect control mechanisms limiting platelet proinflammatory activity. However, platelets significantly upregulated monocyte MMP-1 mRNA accumulation and protein secretion in the presence of the additional stimulus of M.tb infection. There was a concurrent increase in the MMP-1 activating enzyme MMP-10, and upregulation was not associated with any concurrent increase in TIMP secretion. Consequently, functional collagen degradation was increased markedly in platelet-monocyte coculture.
The platelet-dependent upregulation of monocyte IL-1b further demonstrates that platelets drive monocyte inflammatory responses, because IL-1b is essential for nitric oxide production, phagosomal acidification and maturation, and adhesion molecule expression (37) . Knockouts of IL-1 activity in pulmonary TB murine models have been used to demonstrate a protective role of this cytokine, which can be associated with polymorphonuclear leukocytes. IL-1b regulates the number and development of granulomas, limits M.tb growth, and is associated with proper induction of other cytokine responses (38, 39) . The upregulation of IL-1b was specific and not observed in either IFN-g or TNF-a secretion. Upregulation of IL-1b has previously been shown to be dependent on caspase-1 processing in M.tb infection (40) , and the data may therefore suggest a role of platelets in the upregulation of inflammasome complexes, such as the caspase-1-NLRP3 inflammasome.
In a novel observation, we found that M.tb-stimulated monocyte MDC secretion is decreased by more than 50% when cocultured with platelets. MDC acts through the CCR4 (C-C chemokine receptor type 4) and is associated with pulmonary inflammation (41) . Such changes in IL-10, IL-12, and MDC are typically attributed to monocytes maturing with an M2 macrophage phenotype. This phenotype is associated with significant tissue remodeling properties, including secretion of MMPs involved in both tissue damage and tissue repair (42) (43) (44) (45) . Prolonged M.tb infection tilts monocyte-derived cells towards an M2 phenotype, which is the major phenotype found in TB granulomas (46) . Our data indicate that platelets may be involved in driving such differentiation. M2-type monocyte-derived macrophages are also associated with increased bacterial replication and progression of disease in patients with TB (47, 48) . We observed increased IL-10, which enhances mycobacterial intracellular survival and growth by suppressing innate and adaptive immune responses (49, 50) , but decreased IL-12, which is strongly associated with M.tb killing (51). Colony-forming unit analysis of cell lysates reflected this, as we observed a 2.5-fold increase in intracellular survival of M.tb in monocytes with platelet coculture compared with those without coculture. The lack of effect by platelets on extracellular colonyforming unit counts suggests that platelets do not affect internalization of M.tb by monocytes.
In the murine model, we demonstrated platelets concentrated at the site of TB pathology in the lung. There were platelets in some alveolar air pockets, and this is consistent with the breakdown of the epithelial barrier resulting in the common symptom of hemoptysis. The images also showed platelets associated with nucleated cells. This is consistent with both tight platelet adherence to recruited cells as they extravasate from the blood vessels and platelet phagocytosis during monocyte maturation (52) . Further magnification revealed that most of the CD41 staining was associated with nuclei of developing multinucleated cells. This supports previous immunohistochemistry of human TB lung detecting the platelet integrin CD42b, which demonstrated that monocyte phagocytosis of platelets drives development of multinucleated giant cells (24) .
Finally, the analysis of BALF samples from human patients with TB demonstrated upregulation of PDGF-BB, P-selectin, RANTES, and CD40L, consistent with platelet activation in pulmonary TB. These mediators correlated with activity of specific MMPs, including the important collagenase MMP-1, and are consistent with our cellular data. Previous work found that PDGF-BB concentrations in the epithelial lining fluid after 6 months of treatment correlated with worsening pulmonary fibrosis scores (53) . The role of platelets in long-term immunopathology and fibrosis after TB infection merits further study. In summary, we demonstrated that markers of platelet activity are increased in plasma of patients with pulmonary TB compared with healthy control subjects, and these are then normalized with antimycobacterial treatment. We demonstrate that platelets alter the proinflammatory response, resulting in increased tissue destruction and development of an IL-1 b, IL-10-high, IL-12-low milieu that is associated with increased pathogen growth. Platelets are present within the infected lung tissue itself and active in human disease. In TB, large-scale tissue damage and bacterial replication are associated with onward transmission, morbidity, and mortality. Our data indicate a previously unappreciated role for platelets in driving this pathology, which may have implications for host-directed therapies in the era of increasing drug resistance. n Author disclosures are available with the text of this article at www.atsjournals.org.
